AerospacePrep logo AerospacePrep CAsP Aerospace Physiology Board Review

The Nervous System & Synapses

Neuroscience & PhysiologySection I5.4% of exam16 objectives

Study The Nervous System & Synapses interactively →Practice questions, flashcards, figures, and progress tracking in the full AerospacePrep app

SECTION ONE

Foundations of Human Physiology

CHAPTER 4 | THE NERVOUS SYSTEM & SYNAPSES

Neural Signaling, Synaptic Transmission & Autonomic Control — Objectives 4.1 through 4.16

The nervous system is the command and control infrastructure of the human body — detecting change in the environment, processing that information at extraordinary speed, and generating precisely targeted responses that maintain physiological homeostasis. In aviation, the nervous system is not background anatomy: it is the substrate of consciousness, the generator of spatial awareness, the regulator of heart rate and vascular tone under G-loading, and the target of hypoxia’s most dangerous effects. Every in-flight physiological emergency — hypoxia, spatial disorientation, G-induced loss of consciousness, motion sickness, acceleration atelectasis — ultimately involves disruption of neural function at some level. Mastery of neural physiology provides the mechanistic framework to explain, predict, and mitigate these hazards.

This chapter covers sixteen objectives spanning neural tissue organization and neuron anatomy (4.1–4.2), the ionic basis of the resting membrane potential (4.3–4.4), the action potential in full mechanistic detail including propagation, velocity, and the all-or-nothing principle (4.5–4.8), synaptic anatomy and transmission (4.9–4.11), neurotransmitters and receptor pharmacology (4.12–4.13), and the anatomy, neurotransmitters, receptors, and functional roles of the autonomic nervous system (4.14–4.16).

Objective 4.1

Describe the organization of the nervous system into central and peripheral divisions, and the functional roles of each division.

Objective 4.2

Describe the anatomy of a typical neuron, including the soma, dendrites, axon, myelin sheath, and nodes of Ranvier.

The nervous system is a functionally unified but anatomically distributed information-processing network. Its organization into divisions reflects not arbitrary anatomy but the distinct roles of different neural populations in detecting stimuli, integrating responses, and executing commands. The neuron, the fundamental signaling unit, is architecturally specialized for its functions of receiving, integrating, conducting, and transmitting electrochemical signals — often over remarkable distances at remarkable speeds.

Organization of the Nervous System (Objective 4.1)

Central Nervous System (CNS)

The CNS consists of the brain and spinal cord — the integration and command centers of the nervous system. The brain is subdivided into:

  • Cerebral cortex and cerebrum: Higher cognitive functions (perception, voluntary movement, language, memory), interpretation of sensory input, and executive control of behavior.
  • Diencephalon (thalamus + hypothalamus): Thalamus: sensory relay station and gateway to the cortex. Hypothalamus: autonomic regulation, endocrine control (via pituitary), circadian rhythms, thermoregulation, hunger, and thirst.
  • Brainstem (midbrain, pons, medulla oblongata): Vital reflex centers (cardiovascular, respiratory, vomiting). Origin of cranial nerves III–XII112. Site of the respiratory rhythm generators (DRG, VRG, pontine centers covered in Chapter 1). Reticular activating system (consciousness). Vestibular nuclei (balance and spatial orientation).
  • Cerebellum: Coordination and timing of movement, balance, sensorimotor integration. Damage produces ataxia (uncoordinated movement)12 — relevant to spatial disorientation assessment.

The spinal cord serves as both a conduit (ascending sensory tracts carry information to the brain; descending motor tracts carry commands to muscles) and an integration center (spinal reflexes can occur without brain involvement — e.g., the withdrawal reflex).

Peripheral Nervous System (PNS)

The PNS comprises all neural tissue outside the brain and spinal cord: the cranial nerves (12 pairs), spinal nerves (31 pairs), and their associated ganglia and sensory receptors. The PNS is functionally subdivided:

  • Somatic PNS: Afferent division: carries sensory information from skin, muscles, and joints to the CNS (touch, pain, temperature, proprioception). Efferent division: carries motor commands from the CNS to skeletal muscles (voluntary movement). Somatic efferents are under conscious control.
  • Autonomic PNS: Regulates involuntary functions of visceral organs — heart, blood vessels, glands, smooth muscle of the gastrointestinal tract, lungs, and bladder. Subdivided into sympathetic (thoracolumbar outflow; ‘fight or flight’) and parasympathetic (craniosacral outflow; ‘rest and digest’) divisions. The autonomic nervous system is detailed in Objectives 4.14–4.16.

Table 4.1. Organization of the Nervous System: Divisions and Functional Roles

DivisionComponentsPrimary FunctionsVoluntary Control
CNSBrain + spinal cordIntegration, processing, command generation, reflex arcs, higher cognitionYes (cortical) + Involuntary (brainstem/spinal)
Somatic PNS (Afferent)Sensory neurons from skin, muscles, jointsSomatosensory input (touch, pain, temp, proprioception)No (involuntary detection)
Somatic PNS (Efferent)Motor neurons to skeletal muscleVoluntary movementYes
Autonomic PNS (Sympathetic)Thoracolumbar ganglia + postganglionic fibersFight/flight: ↑ HR, ↑ BP, bronchodilation, pupil dilation, vasoconstriction in viscera/skinNo (involuntary)
Autonomic PNS (Parasympathetic)Craniosacral ganglia + postganglionic fibersRest/digest: ↓ HR, bronchoconstriction, digestion, salivation, pupil constrictionNo (involuntary)
Enteric Nervous SystemIntrinsic GI neurons (‘second brain’)GI motility and secretion (semi-independent of CNS/ANS)No

Anatomy of a Typical Neuron (Objective 4.2)

The neuron is the basic structural and functional unit of the nervous system. Despite enormous diversity in size, shape, and specialization, all neurons share a common architectural plan optimized for receiving, integrating, and transmitting electrical signals. The ~86 billion neurons of the human nervous system12 are supported by an even greater number of glial cells (astrocytes, oligodendrocytes, microglia, Schwann cells) that provide structural support, metabolic sustenance, myelin insulation, and immune surveillance.

Soma (Cell Body)

The soma is the metabolic center of the neuron — the largest component by volume in most neurons. It contains the nucleus (with genetic instructions for protein synthesis), abundant rough endoplasmic reticulum (Nissl bodies — sites of protein synthesis for membrane channels, neurotransmitters, and structural proteins), Golgi apparatus (for vesicle formation and protein processing), and a large population of mitochondria (reflecting the high metabolic demands of neural signaling). The soma integrates incoming signals from dendrites and initiates action potentials at the axon hillock.

Dendrites

Dendrites are the primary input structures of the neuron — highly branched extensions of the soma that dramatically increase the receptor surface area. Each dendrite receives synaptic input from hundreds to thousands of other neurons. Dendritic spines — tiny protrusions on the dendritic shaft — are the primary sites of excitatory synaptic contact in the CNS. The density of dendritic spines is dynamically regulated by synaptic activity and is a structural correlate of synaptic plasticity (long-term potentiation/depression, learning). Dendritic signals are graded (not all-or-nothing) and decay with distance; their summation at the axon hillock determines whether an action potential is generated.

Axon and Axon Hillock

The axon is the output fiber of the neuron — it conducts action potentials from the soma to the axon terminals. Key structural features:

  • Axon hillock: The cone-shaped region where the axon arises from the soma. This is the spike initiation zone — the site with the highest density of voltage-gated sodium channels and therefore the lowest threshold for action potential generation. Graded potentials from the dendrites and soma summate here; if the depolarization exceeds threshold (∼−55 mV in most neurons), an action potential is generated.
  • Axon proper: Conducts the action potential without decrement (all-or-nothing). May be up to 1 meter long in peripheral motor neurons (e.g., sciatic nerve). The axon is wrapped in myelin (in myelinated neurons) or is unmyelinated.
  • Axon terminals (synaptic boutons): The branching endpoint of the axon where synaptic vesicles containing neurotransmitters are stored and released. Each axon may branch into hundreds or thousands of terminals, allowing one neuron to influence many target cells (divergence).

Myelin Sheath

Myelin is a lipid-rich insulating material produced by oligodendrocytes (in the CNS) or Schwann cells (in the PNS)1212. Each oligodendrocyte can myelinate segments of up to 40 different axons; each Schwann cell myelinates a single axon segment. Myelin dramatically increases the speed of action potential propagation by increasing membrane resistance and reducing capacitance between nodes of Ranvier. Structurally, myelin consists of concentric wraps of the glial cell membrane, forming a multilayered sheath of lipid bilayers around the axon.

Clinical relevance: Demyelinating diseases (multiple sclerosis in the CNS; Guillain-Barré syndrome in the PNS) destroy myelin, slowing and ultimately blocking action potential propagation. The clinical manifestations — weakness, sensory deficits, autonomic instability — directly reflect the myelin loss in affected pathways.

Nodes of Ranvier

Nodes of Ranvier are the small gaps (≈1–2 μm) between adjacent myelin segments where the axon membrane is directly exposed to the extracellular fluid. These nodes are densely packed with voltage-gated sodium channels (approximately 1000–12,000 per μm² at nodes, compared to <25 per μm² under the myelin)24. Action potentials can only occur at nodes — the action potential ‘jumps’ from node to node in myelinated fibers (saltatory conduction, from Latin saltare: to leap), covering large internodal distances of 1–2 mm per jump12. Internodal spacing increases with axon diameter. This jumping pattern dramatically reduces the ion flux and energy expenditure needed for signal conduction.

Aviation Application — Neural integrity and aerospace physiology

The functional performance of the nervous system — from peripheral sensory transduction through central processing to motor output — is exquisitely sensitive to the physiological conditions of flight. Hypoxia preferentially targets the cerebral cortex first (frontal lobe executive function, judgment, and self-assessment) before affecting subcortical structures. The cerebellar ataxia of acute hypoxia reflects cerebellar neuron vulnerability. The spatial disorientation of vestibulo-ocular mismatch involves the vestibular nuclei of the brainstem and their cortical projections. Motion sickness results from sensory conflict between vestibular, visual, and proprioceptive inputs reaching the brainstem. Every neural anatomy fact in this chapter has a direct aviation physiology application.

Myelination and conduction velocity in performance context: The large myelinated motor axons that drive skeletal muscle contraction (A-alpha fibers, 70–120 m/sec conduction velocity) enable the split-second motor responses required for aircraft control inputs. In contrast, unmyelinated C fibers conducting pain signals at 0.5–2 m/sec represent the opposite end of the spectrum. The selective vulnerability of large myelinated fibers to compression (sitting on a nerve) and to demyelinating disease illustrates why specific neural function losses can be anatomically predicted.

High-Yield Summary
  • CNS = brain + spinal cord. PNS = all neural tissue outside CNS (cranial nerves, spinal nerves, ganglia).
  • ANS divisions: Sympathetic (thoracolumbar; fight/flight) vs. Parasympathetic (craniosacral; rest/digest). Both involuntary.
  • Neuron anatomy: Dendrites (input) → Soma (integration) → Axon hillock (spike initiation; highest Na⁺ channel density) → Axon (conduction) → Terminals (output/neurotransmitter release).
  • Myelin: Oligodendrocytes (CNS) and Schwann cells (PNS). Increases resistance, reduces capacitance → faster conduction.
  • Nodes of Ranvier: Gaps between myelin segments. High Na⁺ channel density. Site of action potential regeneration in myelinated fibers.
  • Saltatory conduction: Action potential ‘jumps’ node-to-node in myelinated fibers → faster, more energy-efficient than continuous conduction.
Objective 4.3

Describe the ionic basis of the resting membrane potential, including the roles of K⁺, Na⁺, and the Na⁺/K⁺-ATPase pump.

Objective 4.4

Explain how the resting membrane potential is maintained and state its typical value in neurons.

Before a neuron can generate or transmit any signal, it must maintain a precisely regulated electrical state across its membrane — the resting membrane potential. This potential, approximately −70 to −90 mV in most neurons12, is not a passive equilibrium but an actively maintained electrochemical disequilibrium that stores potential energy available for rapid release during neural signaling. Understanding its ionic basis is prerequisite to understanding why action potentials occur, how hypoxia impairs neuronal function, and why certain ions play such central roles in pharmacology and toxicology relevant to aviation.

Ion Concentration Gradients Across the Neuronal Membrane

The neuronal membrane separates two distinct ionic environments that differ dramatically in composition. The intracellular fluid (ICF) is relatively rich in potassium (K⁺) and large, impermeant organic anions (proteins, phosphates). The extracellular fluid (ECF) is relatively rich in sodium (Na⁺) and chloride (Cl⁻). These concentration differences are maintained by active transport (the Na⁺/K⁺-ATPase pump) and by the selective permeability of the membrane. They are the energy reservoir from which all membrane potential changes draw their power.

Table 4.2. Ionic Concentrations and Resting Membrane Permeability in a Typical Neuron

IonIntracellular Conc. (mEq/L)Extracellular Conc. (mEq/L)Equilibrium Potential (Nernst)Resting Membrane Permeability
K⁺ (Potassium)~140 mEq/L (high inside)~4 mEq/L (low outside)~−94 mVHIGH: K⁺ leak channels open at rest
Na⁺ (Sodium)~14 mEq/L (low inside)~142 mEq/L (high outside)~+61 mVLOW: voltage-gated channels closed at rest
Cl⁻ (Chloride)~4 mEq/L (low inside)~103 mEq/L (high outside)~−86 mVModerate: some leak channels
A⁻ (Organic anions)~140 mEq/L (large; cannot exit)~0 mEq/LZERO: impermeant; trapped inside

Mechanism of the Resting Membrane Potential (Objectives 4.3 + 4.4)

Step 1: K⁺ Leak Channels and the Dominant K⁺ Contribution

At rest, the neuronal membrane contains a large number of constitutively open potassium leak channels (also called K⁺ two-pore domain channels). Because intracellular [K⁺] is approximately 35 times higher than extracellular [K⁺]124, there is a powerful chemical (concentration) gradient driving K⁺ outward through these channels. As K⁺ diffuses outward, it carries positive charges out, leaving behind the impermeant intracellular anions (A⁻). This creates an electrical gradient (inside becomes more negative; outside more positive) that opposes further K⁺ efflux.

Equilibrium for K⁺ is reached when the chemical gradient (driving K⁺ out) exactly equals the electrical gradient (opposing K⁺ efflux). The membrane potential at this equilibrium is called the Nernst potential for K⁺ (≈ −94 mV)124. Since K⁺ is the dominant ion determining resting potential, the actual resting membrane potential is close to (but not quite equal to) the K⁺ Nernst potential.

Step 2: Small Na⁺ Leak and Its Depolarizing Influence

At rest, the membrane is not perfectly impermeable to Na⁺. A small but constant Na⁺ leak current flows inward, driven by both the concentration gradient (Na⁺ is 10× more concentrated outside) and the electrical gradient (the negative inside attracts positive Na⁺). This small inward Na⁺ current slightly depolarizes the membrane from the pure K⁺ Nernst potential of −94 mV toward −90 mV (the typical resting membrane potential of large myelinated neurons) or −70 mV (typical of many CNS neurons). The Na⁺ permeability at rest is approximately 1/100 of the K⁺ permeability — small but not zero12.

Step 3: The Na⁺/K⁺-ATPase Pump — Maintaining the Disequilibrium

Without active correction, the small inward Na⁺ leak would gradually accumulate intracellular Na⁺ while the outward K⁺ leak would deplete intracellular K⁺ — progressively collapsing the concentration gradients that power the resting potential. The Na⁺/K⁺-ATPase pump (sodium-potassium pump) continuously counteracts this tendency:

  • For every ATP hydrolyzed, the pump moves 3 Na⁺ OUT of the cell and 2 K⁺ IN to the cell113.
  • This is an electrogenic pump (net charge transfer: 3 positive out vs. 2 positive in = 1 net positive charge exported per cycle), contributing approximately −4 mV directly to the resting membrane potential12.
  • Its primary role is to maintain the K⁺ and Na⁺ concentration gradients that are the energy source for all electrical signaling.
  • The pump is ATP-dependent: hypoxia reduces ATP production → pump failure → intracellular Na⁺ rises, intracellular K⁺ falls → depolarization → abnormal neuronal firing → cellular dysfunction.

The Resting Membrane Potential (Summary)

RMP ≈ −70 to −90 mV (inside negative relative to outside)

Determined primarily by K⁺ leak (dominant)

Modified by small Na⁺ leak (partially depolarizing)

Maintained by Na⁺/K⁺-ATPase pump (electrogenic: +−4 mV)

Aviation Application — Hypoxia and the Na⁺/K⁺ pump

The Na⁺/K⁺-ATPase pump is one of the most energy-intensive processes in the body, consuming approximately 20–40% of resting cellular ATP in neurons12. The brain, which constitutes only 2% of body weight, consumes approximately 20% of the body’s total oxygen consumption at rest12 — primarily to fuel this pump and the re-establishing of ion gradients after each action potential. When cerebral oxygen delivery falls (during hypoxic exposure, G-LOC, or CO poisoning), ATP production falls within seconds. Na⁺/K⁺ pump activity declines, intracellular Na⁺ rises, cells depolarize, voltage-gated channels activate inappropriately, and neuronal function fails. This is the cellular mechanism underlying the cognitive impairment and eventual loss of consciousness in cerebral hypoxia. It explains why the brain tolerates only 4–6 seconds of total ischemia before consciousness is lost1410 — the ATP reserves at rest are exhausted in seconds, and the Na⁺/K⁺ pump cannot be maintained.

Potassium and cardiac relevance: The resting membrane potential principles described here apply to cardiac muscle cells as well as neurons. Hyperkalemia (elevated serum K⁺) reduces the K⁺ concentration gradient, makes the equilibrium potential for K⁺ less negative, depolarizes the resting membrane potential of cardiac cells closer to threshold, and can cause spontaneous cardiac depolarization and arrhythmia. Dehydration-induced hypokalemia has the opposite effect but increases membrane excitability in a different way. Electrolyte management during prolonged flight depends on these ionic mechanisms.

High-Yield Summary
  • Resting membrane potential: −70 to −90 mV (inside negative). Large myelinated neurons: −90 mV; many CNS neurons: −65 to −70 mV.
  • K⁺: 140 mEq/L inside vs. 4 mEq/L outside. Nernst K⁺ potential: −94 mV. K⁺ leak channels open at rest → dominant determinant of RMP.
  • Na⁺: 14 mEq/L inside vs. 142 mEq/L outside. Nernst Na⁺ potential: +61 mV. Small Na⁺ leak at rest → slightly depolarizes from pure K⁺ Nernst potential.
  • Na⁺/K⁺-ATPase: Pumps 3 Na⁺ OUT + 2 K⁺ IN per ATP. Electrogenic (approximately −3 to −4 mV direct contribution). Maintains concentration gradients. ATP-dependent → fails in hypoxia113.
  • Hypoxia → ↓ ATP → pump fails → ↑ intracellular Na⁺, ↓ intracellular K⁺ → depolarization → loss of neuronal function. This is the cellular basis of hypoxic cerebral impairment.
Objective 4.5

Describe the sequence of ionic events that generate an action potential, including threshold, depolarization, repolarization, and hyperpolarization (after-potential).

Objective 4.6

State the all-or-nothing principle and explain its significance for neural signaling.

Objective 4.7

Describe how action potentials propagate along unmyelinated and myelinated nerve fibers, explaining the concept of saltatory conduction.

Objective 4.8

List the factors that determine conduction velocity and describe the functional classification of nerve fibers.

The action potential is the fundamental unit of neural signaling — the brief, stereotyped electrical event that travels without diminution along the axon, carrying information from one location to another. Its generation is the culmination of the ionic disequilibrium established by the resting membrane potential; its propagation is the mechanism by which that information traverses the centimeters to meters of axonal length between its source and target. Understanding the action potential at this mechanistic level is prerequisite to understanding how signal frequency encodes information intensity, how nerve agents work, why myelination is essential for rapid neural function, and how hypoxia specifically impairs high-speed neural conduction.

The Ionic Sequence of the Action Potential (Objective 4.5)

Phase 1: Resting State (RMP ≈ −70 to −90 mV)

At rest, voltage-gated sodium channels are in the ‘closed but activatable’ (resting) state — activation gates closed, inactivation gates open. Voltage-gated potassium channels are also closed. The resting membrane potential is maintained primarily by K⁺ leak channels and the Na⁺/K⁺ pump, as described in Objectives 4.3–4.4.

Phase 2: Threshold and Initiation (Approx. −55 to −50 mV)

When the membrane is depolarized (made less negative) to the threshold potential — approximately −55 mV in many neurons12, representing a ≈15–35 mV depolarization from rest — a critical positive-feedback process begins. At threshold, the fraction of open voltage-gated Na⁺ channels becomes sufficient to produce an inward Na⁺ current that exceeds the outward K⁺ current. This initiates a self-regenerating ‘explosive’ depolarization:

  • Depolarization → more voltage-gated Na⁺ channels open → more Na⁺ enters → more depolarization → still more Na⁺ channels open…

This autocatalytic positive feedback is the hallmark of threshold phenomena and explains the all-or-nothing nature of action potentials. Once threshold is reached, the action potential proceeds to completion regardless of the triggering stimulus.

Phase 3: Depolarization / Rising Phase (+20 to +30 mV)

The rapid opening of voltage-gated Na⁺ channels causes a 100× increase in Na⁺ permeability. Na⁺ rushes inward driven by both the concentration gradient (outside >> inside) and the electrical gradient (the negative inside attracts positive Na⁺). The membrane potential rises rapidly from −55 mV to approximately +30 mV125 — the membrane has reversed polarity (inside transiently positive). This ‘overshoot’ approaches but does not reach the Na⁺ Nernst potential (+61 mV) because two processes begin to terminate depolarization.

Phase 4: Repolarization / Falling Phase

Two simultaneous processes restore the negative membrane potential:

  • Na⁺ channel inactivation: Within approximately 0.5–1 ms after opening, voltage-gated Na⁺ channels undergo inactivation124 — the inactivation gate (h-gate) swings closed, blocking the channel despite the activation gate remaining open. Na⁺ permeability falls to near zero.
  • Delayed K⁺ channel opening: Voltage-gated K⁺ channels, activated by the same depolarization that opened Na⁺ channels but with a time delay, now open and allow rapid K⁺ efflux. K⁺ rushes outward driven by the concentration gradient (high inside) and, transiently, by the reversed electrical gradient (positive inside repels K⁺). K⁺ efflux rapidly repolarizes the membrane back toward negative.

Phase 5: After-Hyperpolarization (Undershoot)

The voltage-gated K⁺ channels close more slowly than the membrane potential returns to rest. During the interval when K⁺ channels are still open but Na⁺ channels have recovered from inactivation, the membrane hyperpolarizes briefly below the resting level — reaching approximately −80 to −95 mV12. This after-hyperpolarization (after-potential) reflects the transient excess K⁺ permeability driving the membrane toward the K⁺ Nernst potential (−94 mV). The membrane then returns to the true resting potential as K⁺ channels gradually close.

Table 4.3. Ionic Events During the Action Potential

PhaseApproximate VmNa⁺ Channel StateK⁺ Channel StateDominant Ion Movement
Resting−70 to −90 mVClosed (activation gate closed; inactivation gate OPEN)ClosedPassive K⁺ leak outward; small Na⁺ leak inward
Threshold∼−55 mVBeginning to open (autocatalytic threshold reached)Closed↑ Na⁺ inward begins to dominate
Depolarization (Rising phase)−55 to +30 mVOPEN (activation gate open; inactivation gate open)Closed (delayed)Massive Na⁺ inward rush; membrane reverses polarity
Repolarization (Falling phase)+30 to −70 mVInactivated (activation gate open; inactivation gate CLOSED)OPEN (delayed opening)Na⁺ permeability ↓ to zero; K⁺ floods outward
After-hyperpolarization−70 to −95 mVRecovering from inactivation; closed (activatable)Slowly closingExcess K⁺ efflux; membrane overshoots toward K⁺ Nernst potential
Return to resting−70 to −90 mVClosed (activatable; fully recovered)ClosedNa⁺/K⁺ pump restores gradients; K⁺ channels close

The All-or-Nothing Principle (Objective 4.6)

The all-or-nothing principle states that a neuron either generates a full action potential or none at all — there is no partial or diminished action potential from a given neuron. The amplitude and shape of the action potential are constant regardless of the strength of the triggering stimulus. A stimulus that reaches threshold always produces the same action potential; a stimulus that fails to reach threshold produces no action potential. Graded subthreshold stimuli produce only local potentials that do not propagate.

This principle has profound implications for neural coding. If action potentials are all identical (constant amplitude, constant shape), how does the nervous system encode different intensities of stimulation? The answer is frequency coding: stronger stimuli produce higher-frequency trains of action potentials12 (more action potentials per second), while weaker stimuli produce lower-frequency trains. The brain interprets stimulus intensity from the frequency (rate) and temporal pattern of action potential firing, not from the amplitude of individual action potentials.

Absolute and Relative Refractory Periods

Two refractory periods follow each action potential and limit the maximum firing frequency of neurons:

  • Absolute refractory period: The interval during which no stimulus, regardless of strength, can generate a new action potential. This corresponds to the period of Na⁺ channel inactivation (approximately 0.5–1 ms)12. Inactivated channels cannot be reopened until they recover from inactivation, which requires repolarization toward rest. The absolute refractory period sets the theoretical maximum firing rate of a neuron (approximately 1000–2000 Hz for neurons with a 0.5–1 ms ARP)12.
  • Relative refractory period: The interval following the absolute refractory period during which a new action potential can be generated, but only by a stronger-than-normal stimulus. This corresponds to the after-hyperpolarization phase, when the K⁺ channels are still partially open, making the membrane more negative than rest and requiring more depolarization to reach threshold. During the relative refractory period, the threshold is elevated — action potentials can be triggered but require greater input.

Action Potential Propagation (Objective 4.7)

Unmyelinated Fibers: Continuous Conduction

In unmyelinated fibers (C fibers and some autonomic fibers), the action potential propagates by local current flow: the depolarized region (inside positive) creates an electrical current that flows to the adjacent resting membrane (inside negative), depolarizing it to threshold and triggering a new action potential. This process repeats continuously along the entire length of the axon — a ‘rolling wave’ of depolarization-repolarization advancing in one direction (the region just behind the advancing action potential is refractory, preventing backward propagation). This continuous conduction is slow (0.5–2 m/sec for C fibers)126 because every segment of the axon membrane must be sequentially depolarized.

Myelinated Fibers: Saltatory Conduction

In myelinated fibers, myelin dramatically increases membrane resistance and reduces membrane capacitance between nodes of Ranvier. The local depolarizing current generated at an active node therefore does not dissipate locally but flows efficiently along the axon to the next node — a distance of 1–2 mm. Since voltage-gated Na⁺ channels are concentrated only at nodes (not under myelin), the action potential regenerates only at nodes, appearing to ‘jump’ from node to node (saltatory conduction, from Latin saltare). This confers two major advantages:

  • Speed: Saltatory conduction is much faster (up to 70–120 m/sec for large A-alpha fibers)126 than continuous conduction in unmyelinated fibers, because the action potential travels the internodal distance passively (almost at electronic speed) and is regenerated only at nodes.
  • Energy efficiency: Only the nodal membrane undergoes ion flux; the myelinated internode is electrically passive. Far fewer Na⁺ and K⁺ ions must be actively pumped back by the Na⁺/K⁺-ATPase after each action potential, reducing the ATP cost of signaling by approximately 100-fold compared to continuous conduction of the same fiber diameter12.

Conduction Velocity and Fiber Classification (Objective 4.8)

Nerve fiber conduction velocity is primarily determined by two factors: fiber diameter (larger diameter = faster conduction) and myelination (myelinated >> unmyelinated at the same diameter)16. These factors together define the functional fiber classification system used in neurophysiology:

Table 4.4. Functional Classification of Peripheral Nerve Fibers

ClassificationSubtypeDiameter (μm)MyelinationVelocity (m/sec)Function
Type A (largest)Aα (alpha)12–20Heavily myelinated70–120Motor to skeletal muscle; proprioception (muscle spindle Ia afferents)
Type AAβ (beta)5–12Myelinated30–70Touch, pressure, vibration (cutaneous mechanoreceptors)
Type AAγ (gamma)3–6Myelinated15–30Motor to muscle spindle intrafusal fibers
Type A (smallest)Aδ (delta)1–5Lightly myelinated5–30Fast pain; cold temperature; some touch
Type B1–3Lightly myelinated3–15Preganglionic autonomic fibers
Type C (smallest)0.2–1.5Unmyelinated0.5–2Slow pain; temperature; postganglionic autonomic fibers
Aviation Application — Nerve agent (organophosphate) poisoning and the action potential

Nerve agents — sarin, VX, novichok, tabun — are irreversible inhibitors of acetylcholinesterase (AChE)1011, the enzyme that terminates acetylcholine action at synapses and the neuromuscular junction. By preventing ACh hydrolysis, nerve agents cause continuous, unremitting depolarization of all acetylcholine-responsive membranes: neuromuscular junctions (leading to persistent muscle depolarization, fasciculations, then paralysis from depolarizing block), muscarinic receptors of secretory glands (causing excessive secretions — the SLUDGE/DUMBELS mnemonics of toxidrome), and CNS neurons. The seizures produced reflect uncontrolled neuronal activation from unchecked cholinergic signaling. In operational environments where nerve agent exposure is a threat, both the mechanism and the logic of antidotal treatment are essential: atropine blocks muscarinic receptors (reducing secretion and bronchospasm); pralidoxime (2-PAM) regenerates AChE if given before aging; benzodiazepines control seizures.

Large A-alpha fiber vulnerability to hypoxia: The fast-conducting large myelinated A-alpha fibers that drive voluntary motor control are among the first neural elements to fail during progressive hypoxia. Their high metabolic rate (required to maintain ion gradients for rapid repetitive firing) makes them vulnerable to ATP depletion. The progressive motor coordination failure seen in hypobaric altitude chamber subjects — beginning with fine motor degradation before gross motor function is lost — reflects the relative vulnerability of these high-speed, high-frequency motor pathways.

High-Yield Summary
  • Action potential phases: Rest (−90 mV) → Threshold (−55 mV; positive feedback) → Depolarization (Na⁺ inrush to +30 mV) → Repolarization (Na⁺ inactivation + K⁺ efflux) → After-hyperpolarization (↓ to −80 mV) → Return to rest.
  • Na⁺ channel has two gates: Activation gate (opens with depolarization) and inactivation gate (closes with sustained depolarization). Inactivation gate closure = absolute refractory period.
  • All-or-nothing: Action potential amplitude is constant. Stimulus intensity is encoded by FREQUENCY (rate) of action potential firing, not amplitude.
  • Absolute refractory period: No stimulus can re-excite (Na⁺ channels inactivated). ≈0.5–1 ms. Max theoretical firing rate: 1000–2000 Hz.
  • Relative refractory period: AP possible only with supra-threshold stimulus. During after-hyperpolarization (K⁺ channels still open).
  • Unmyelinated (C fiber): Continuous conduction; 0.5–2 m/sec. Myelinated (A-alpha): Saltatory conduction; 70–120 m/sec. Saltatory is faster AND more energy-efficient.
  • Conduction velocity ∝ fiber diameter + myelination. Aα (70–120 m/sec) → Aβ → Aγ → Aδ (5–30 m/sec) → B → C (0.5–2 m/sec).
Objective 4.9

Describe the anatomy of a chemical synapse, including presynaptic terminal, synaptic cleft, and postsynaptic membrane.

Objective 4.10

Describe the sequence of events in synaptic transmission from action potential arrival to postsynaptic response.

Objective 4.11

Distinguish between excitatory and inhibitory postsynaptic potentials (EPSPs and IPSPs), and explain how spatial and temporal summation determine whether a neuron fires.

The synapse is the junction between two neurons (or between a neuron and an effector cell) where electrochemical information is transmitted from one cell to the next. Unlike the action potential, which is an all-or-nothing binary event, synaptic transmission is a graded, modulatable process — the functional strength of synapses changes with use, learning, disease, and pharmacological intervention. The synapse is the locus of nearly all clinically significant neuroactive drug action, the site of pathology in diseases ranging from myasthenia gravis to Parkinson’s disease, and the target of several classes of chemical weapons. It is also the site where the speed advantage of neural versus hormonal signaling is achieved: the synaptic delay is only 0.3–5 milliseconds12.

Anatomy of the Chemical Synapse (Objective 4.9)

Presynaptic Terminal (Synaptic Bouton)

The presynaptic terminal is the specialized ending of the presynaptic axon that faces the postsynaptic cell. It contains:

  • Synaptic vesicles: Membrane-bound spheres (40–60 nm diameter) containing high concentrations of a specific neurotransmitter. Each vesicle holds approximately 5,000–10,000 neurotransmitter molecules27. Vesicles are concentrated near the active zone — specialized regions of the presynaptic membrane containing docking proteins (SNARE complex: syntaxin, SNAP-25, synaptobrevin) and voltage-gated Ca²⁺ channels aligned for maximal vesicle fusion efficiency.
  • Voltage-gated Ca²⁺ channels: Concentrated at active zones. Ca²⁺ entry is the trigger for neurotransmitter release. The Ca²⁺ channels are closely coupled to vesicle docking sites, enabling release within microseconds of channel opening.
  • Mitochondria: Abundant, reflecting the high energy demand of neurotransmitter synthesis, vesicle trafficking, and membrane recycling.
  • Reuptake transporters: Transmembrane proteins that actively recapture released neurotransmitter molecules from the synaptic cleft for repackaging and reuse.

Synaptic Cleft

The synaptic cleft is the extracellular space between presynaptic and postsynaptic membranes — approximately 20–50 nm wide12. It is not empty: it contains a basal lamina (extracellular matrix) rich in collagen, laminin, and fibronectin that anchors both membranes and contains enzymes (e.g., acetylcholinesterase at the neuromuscular junction) that inactivate released neurotransmitter. The narrow cleft ensures that released neurotransmitter rapidly diffuses to postsynaptic receptors rather than dispersing into the bulk extracellular fluid.

Postsynaptic Membrane

The postsynaptic membrane is the specialized membrane of the postsynaptic cell (dendrite, soma, or muscle cell) directly facing the presynaptic terminal. It contains:

  • Neurotransmitter receptors: Ligand-gated ion channels (ionotropic receptors) or G-protein-coupled receptors (metabotropic receptors) that respond to specific neurotransmitters. Ionotropic receptors produce fast responses (milliseconds); metabotropic receptors produce slower but often more sustained and widespread effects (seconds to minutes).
  • Postsynaptic density (PSD): A protein scaffold that organizes and concentrates receptors precisely opposite the active zone, maximizing exposure to released transmitter.
  • Voltage-gated channels: In some postsynaptic membranes (notably muscle cells), voltage-gated Na⁺ channels adjacent to the receptor zone amplify the receptor-generated potential change.

Sequence of Synaptic Transmission (Objective 4.10)

Chemical synaptic transmission is a precisely orchestrated sequence of molecular events that converts an electrical signal (presynaptic action potential) into a chemical signal (neurotransmitter release) and back into an electrical signal (postsynaptic potential):

  • An action potential arrives at the presynaptic terminal, depolarizing the presynaptic membrane.
  • Depolarization opens voltage-gated Ca²⁺ channels in the presynaptic active zone. Ca²⁺ enters the terminal down its concentration gradient (extracellular [Ca²⁺] ≈10,000× higher than intracellular). Intracellular [Ca²⁺] rises dramatically within microseconds of the action potential.
  • The Ca²⁺-SNARE interaction: Rising intracellular Ca²⁺ binds to synaptotagmin (the Ca²⁺ sensor on the vesicle), triggering a conformational change in the SNARE protein complex that pulls the vesicle and plasma membranes into contact and drives fusion (exocytosis). Approximately 125–200 vesicles are released per action potential at a typical neuromuscular junction7 (fewer at central synapses).
  • Neurotransmitter molecules (released by exocytosis) diffuse across the synaptic cleft in approximately 0.1–0.5 ms12. Diffusion is rapid over the short 20–50 nm distance. Multiple receptors are exposed simultaneously.
  • Neurotransmitter binds to receptor proteins on the postsynaptic membrane. Ionotropic receptors (ligand-gated ion channels) open immediately upon binding, allowing ion flux. Metabotropic receptors (GPCRs) activate G-proteins, initiating intracellular signaling cascades.
  • Postsynaptic potential is generated: Depolarizing currents produce an excitatory postsynaptic potential (EPSP); hyperpolarizing currents produce an inhibitory postsynaptic potential (IPSP). These potentials spread electrotonically from the synapse toward the axon hillock.
  • Termination of transmitter action by three mechanisms: (a) Enzymatic degradation (e.g., acetylcholinesterase hydrolyzes ACh in the synaptic cleft within milliseconds). (b) Reuptake by presynaptic transporter proteins (e.g., serotonin, dopamine, norepinephrine transporters). (c) Diffusion out of the cleft into the bulk extracellular fluid.
  • Vesicle membrane is recycled via clathrin-mediated endocytosis within 10–60 seconds. New vesicles are rapidly refilled with neurotransmitter.

EPSPs, IPSPs, and Summation (Objective 4.11)

Excitatory Postsynaptic Potentials (EPSPs)

EPSPs are graded, short-duration (5–10 ms) depolarizations of the postsynaptic membrane produced by excitatory neurotransmitters (e.g., glutamate, acetylcholine). They result from the opening of ionotropic channels that are permeable to Na⁺ (and sometimes Ca²⁺), allowing inward cation flow that depolarizes the membrane toward threshold. A single EPSP is typically too small (≉0.5–1 mV) to reach threshold alone12 — it is a subthreshold graded potential. Reaching threshold requires summation.

Inhibitory Postsynaptic Potentials (IPSPs)

IPSPs are graded, short-duration hyperpolarizations or stabilizations of the postsynaptic membrane produced by inhibitory neurotransmitters (e.g., GABA, glycine). They result from the opening of channels permeable to Cl⁻ (which enters the cell, driving the membrane toward the Cl⁻ equilibrium potential of approximately −70 to −80 mV — more negative than threshold) or K⁺ (which exits, also hyperpolarizing). IPSPs move the membrane further from threshold, making it harder to generate an action potential. IPSPs are not silent — they represent active inhibition that must be overcome by sufficient excitatory input.

Temporal Summation

Temporal summation occurs when multiple action potentials arrive at the same synapse in rapid succession (within the decay time of each EPSP, approximately 5–10 ms). The postsynaptic potentials generated by each successive action potential add to the residual depolarization from the previous one, producing a larger cumulative depolarization. If the summed depolarization reaches threshold at the axon hillock, an action potential is generated. Temporal summation exploits the slow decay of postsynaptic potentials relative to the presynaptic firing rate.

Spatial Summation

Spatial summation occurs when EPSPs from multiple different presynaptic neurons (or multiple synaptic contacts from different locations on the dendritic tree) are generated simultaneously. Their individual contributions travel electrotonically from their respective dendritic sites toward the axon hillock, where they summate. If the sum of all concurrent EPSPs minus all concurrent IPSPs reaches threshold, an action potential is generated. The axon hillock integrates inputs from potentially thousands of synapses arriving simultaneously.

The integration principle: The axon hillock acts as a biological summation device, continuously computing the algebraic sum of all excitatory and inhibitory inputs. An action potential fires if and only if this net depolarization reaches threshold. This integration — not simple relay — is what gives neurons their computational power.

Aviation Application — Botulinum toxin as an aviation occupational hazard

Botulinum toxin (from Clostridium botulinum) is the most potent biological toxin known and acts directly at the neuromuscular junction7. It cleaves SNARE proteins (specifically synaptobrevin for BoNT/B and synaptosomal associated protein 25 for BoNT/A), preventing vesicle fusion and ACh release at all cholinergic synapses. The result is flaccid paralysis — beginning with cranial nerve-innervated muscles (diplopia, dysarthria, dysphagia) and descending to respiratory muscles (respiratory failure). In military aviation, botulinum toxin has bioterrorism potential, making both the mechanism and the clinical progression important for force protection. There is no antidote — only antitoxin (for neutralizing unbound toxin), supportive care, and mechanical ventilation until the toxin is cleared (weeks to months).

Synaptic plasticity and aviation skill: The ability of synapses to strengthen with use (long-term potentiation, LTP)14 and weaken with disuse (long-term depression, LTD) is the cellular mechanism of learning and skill acquisition. The procedural motor skills of aircraft handling, the pattern recognition involved in instrument interpretation, and the emergency procedure responses that must be executed in seconds under hypoxic or G-stressed conditions are all stored in modified synaptic weights in motor cortex, cerebellum, and basal ganglia circuitry. The physiological principle that repetitive high-frequency synaptic activation strengthens synaptic transmission (Hebbian plasticity) is the neural basis for simulator training effectiveness and the rationale for maintaining procedural currency in aviators.

High-Yield Summary
  • Synaptic anatomy: Presynaptic terminal (vesicles, Ca²⁺ channels, mitochondria) — Synaptic cleft (20–50 nm; AChE here) — Postsynaptic membrane (receptors, PSD).
  • Transmission sequence: AP arrival → Ca²⁺ influx (voltage-gated Ca²⁺ channels) → vesicle fusion (SNARE + synaptotagmin) → exocytosis → transmitter diffuses cleft → receptor binding → EPSP or IPSP → axon hillock summation → AP (if threshold reached).
  • EPSP: Graded depolarization (Na⁺/Ca²⁺ inward). Moves toward threshold. Too small alone (≉0.5–1 mV)12 → requires summation.
  • IPSP: Graded hyperpolarization (Cl⁻ in or K⁺ out). Moves away from threshold. Active inhibition.
  • Temporal summation: Multiple APs at SAME synapse in rapid succession → EPSPs add together.
  • Spatial summation: EPSPs from MULTIPLE synapses simultaneously → sum at axon hillock.
  • Termination: (1) Enzymatic degradation (AChE). (2) Reuptake transporters (dopamine, serotonin, NE). (3) Diffusion.
  • Botulinum toxin cleaves SNARE proteins → no vesicle fusion → no ACh release → flaccid paralysis (cranial nerves first; respiratory last).
Objective 4.12

List and describe the major neurotransmitters of the nervous system, their primary locations, and their general functional roles.

Objective 4.13

Distinguish between ionotropic and metabotropic receptors and describe how each type of receptor mediates its postsynaptic effect.

Neurotransmitters are the chemical messengers of the nervous system — the molecules released from presynaptic terminals that bind to receptors on target cells and initiate postsynaptic responses. More than 100 neurotransmitters and neuromodulators have been identified, but a relatively small group of major transmitters mediates the majority of fast neural signaling and autonomic control. Their receptors fall into two fundamentally different classes — ionotropic (fast, direct ion channel) and metabotropic (slow, G-protein-mediated) — that underlie the full spectrum of neural response timescales.

Major Neurotransmitters (Objective 4.12)

Table 4.5. Major Neurotransmitters: Location, Receptors, Function, and Aviation Relevance

NeurotransmitterPrimary LocationReceptor TypesPrimary EffectAviation / Clinical Relevance
Acetylcholine (ACh)Neuromuscular junctions; all preganglionic autonomic neurons; parasympathetic postganglionic; basal forebrain (cognition)Nicotinic (ionotropic); Muscarinic (metabotropic M1–M5)Excitatory at NMJ and nicotinic receptors; variable at muscarinic (organ-dependent)Nerve agent target (AChE inhibition); myasthenia gravis; dementia (cholinergic loss)
GlutamatePrimary excitatory neurotransmitter of the CNS; distributed throughout cortex, hippocampus, cerebellumAMPA, NMDA, kainate (ionotropic); mGluR (metabotropic)EXCITATORY — fast; NMDA involved in synaptic plasticity and learningExcitotoxicity from excessive activation (ischemia, hypoxia, head trauma); basis of LTP/LTD (skill learning)
GABA (γ-aminobutyric acid)Primary inhibitory neurotransmitter of the brain; widespread in CNS (interneurons)GABA-A (ionotropic, Cl⁻ channel); GABA-B (metabotropic)INHIBITORY — reduces neuronal excitability; tonically suppresses seizuresBenzodiazepines, alcohol, and barbiturates enhance GABA-A → sedation, impaired cognition, flying performance degradation
GlycinePrimary inhibitory neurotransmitter of spinal cord and brainstemGlycine receptor (ionotropic, Cl⁻ channel)INHIBITORY — motor and sensory inhibition in spinal cordStrychnine blocks glycine receptors → tetanic muscle spasms; relevant in toxicology
DopamineSubstantia nigra (motor control); ventral tegmentum (reward, motivation, attention)D1–D5 receptors (all metabotropic GPCRs)Modulatory; reward/motivation; fine motor controlDopamine loss → Parkinson’s disease (↓ motor control, fine motor degradation relevant to aircraft control). Hyperdopaminergia → schizophrenia
Norepinephrine (NE)Locus coeruleus (CNS arousal); postganglionic sympathetic neurons (PNS)α1, α2, β1, β2 adrenergic (all metabotropic)CNS: ↑ arousal, attention, fight/flight. PNS: vasoconstriction, ↑ HR, bronchodilation (β2)Sympathetic activation during G-loading; stress response; decongestants (α-agonists) and their cardiovascular side effects
Epinephrine (Adrenaline)Adrenal medulla (circulating hormone > neurotransmitter)α1, α2, β1, β2 adrenergic (GPCRs)Systemic fight/flight: ↑ HR, ↑ contractility, bronchodilation, ↑ blood glucose, peripheral vasoconstrictionPrimary stress hormone during G-loading, hypoxia, and emergency situations; basis of epinephrine auto-injector for anaphylaxis
Serotonin (5-HT)Raphe nuclei of brainstem; enteric nervous system5-HT1–5-HT7 receptors (metabotropic; 5-HT3 is ionotropic)Mood regulation; sleep; appetite; GI motility; some vasomotionSSRIs enhance serotonin → antidepressant effects; sedation, GI effects, and sexual dysfunction relevant to aeromedical evaluation
HistamineHypothalamus (tuberomammillary nucleus); mast cells in peripheryH1–H4 receptors (metabotropic)CNS: arousal and wakefulness. Periphery: inflammation, vasodilation, bronchoconstrictionAntihistamines (H1 blockers) cause sedation → CNS impairment → grounding consideration for aviators
Endorphins / EnkephalinsCNS pain modulation pathways; periaqueductal gray; spinal cord dorsal hornOpioid receptors (μ, δ, κ; all metabotropic GPCRs)Inhibit pain transmission; euphoria; respiratory depression at high dosesOpioid analgesics prescribed for musculoskeletal injuries; grounding until drug cleared; opioid-induced respiratory depression is life-threatening

Receptor Types: Ionotropic vs. Metabotropic (Objective 4.13)

Ionotropic Receptors (Ligand-Gated Ion Channels)

Ionotropic receptors are transmembrane proteins that contain both the neurotransmitter binding site and an ion channel pore within the same protein complex. Neurotransmitter binding causes immediate conformational change, opening the channel within milliseconds. No second messenger is needed; the response is fast and direct.

Examples: Nicotinic ACh receptor (nAChR) at the neuromuscular junction; AMPA and NMDA glutamate receptors; GABA-A receptor; glycine receptor.

  • AMPA receptors: Glutamate binds → Na⁺/K⁺ channel opens → fast EPSP (~1–5 ms). Mediate most fast excitatory transmission in the CNS.
  • NMDA receptors: Require simultaneous glutamate binding AND voltage-dependent Mg²⁺ block removal (from membrane depolarization) AND glycine co-agonist. When both conditions are met, Ca²⁺ enters the cell — this Ca²⁺ influx triggers synaptic plasticity (LTP). NMDA receptors are ‘coincidence detectors’ — they only activate when the presynaptic neuron fires (glutamate release) AND the postsynaptic neuron is already depolarized214. This coincidence detection is the molecular basis of Hebbian learning: ‘neurons that fire together, wire together.’
  • GABA-A receptor: GABA binds → Cl⁻ channel opens → Cl⁻ enters (inside more negative) → IPSP. The binding site for benzodiazepines is on the GABA-A receptor complex (at the interface between α and γ subunits). Benzodiazepines are positive allosteric modulators: they increase the frequency of Cl⁻ channel opening in response to GABA, enhancing inhibition without activating the channel directly. This is the mechanism of sedation, anxiolysis, and anticonvulsant effects — and the mechanism of performance impairment relevant to aviation.

Metabotropic Receptors (G-Protein-Coupled Receptors, GPCRs)

Metabotropic receptors are seven-transmembrane-domain proteins that are coupled to intracellular G-proteins. Neurotransmitter binding activates the G-protein (by promoting GDP → GTP exchange on the Gα subunit), which then activates or inhibits downstream effectors — primarily enzymes that produce second messengers, or directly regulated ion channels.

The response is slower (seconds to minutes) but often more widespread and sustained than ionotropic responses. Second messengers (cAMP, cGMP, IP3, DAG) can diffuse throughout the cell, phosphorylate multiple proteins via kinases, and produce effects on gene expression, ion channel gating, and metabolic processes.

Key GPCR examples in neural physiology:

  • β1-adrenergic receptors (Gs-coupled): NE/Epi bind → Gs → ↑ adenylate cyclase → ↑ cAMP → PKA phosphorylates cardiac L-type Ca²⁺ channels and phospholamban → ↑ heart rate and contractility. The basis of β-blocker pharmacology.
  • M2 muscarinic receptors (Gi-coupled): ACh binds → Gi → ↓ adenylate cyclase → ↓ cAMP + direct Giβγ activation of IKACh → ↓ heart rate. The basis of vagal cardiac slowing and atropine pharmacology.
  • Dopamine D2 receptors (Gi-coupled): Dopamine binds → Gi → inhibits adenylate cyclase → reduces target cell activity. Target of antipsychotic drugs (which block D2 receptors) and of antiparkinsonian drugs (which stimulate them).

Table 4.6. Ionotropic vs. Metabotropic Receptors: Comparative Properties

PropertyIonotropic (Ligand-Gated Ion Channels)Metabotropic (GPCRs)
StructureMulti-subunit transmembrane complex; channel pore integral to receptor proteinSingle polypeptide; 7 transmembrane domains; no pore
MechanismDirect ion channel opening upon ligand bindingG-protein activation → second messengers → intracellular cascades
Response speedMilliseconds (fast)Seconds to minutes (slow)
Response durationBrief (ms to tens of ms)Prolonged (seconds to hours)
AmplificationNone (stoichiometric: 1 receptor = 1 channel)High (1 receptor → many G-proteins → many effectors)
SelectivitySpecific ion(s) per channel typeBroad (second messengers affect many targets)
ExamplesnAChR (Na⁺/K⁺); AMPA (Na⁺/K⁺); NMDA (Ca²⁺); GABA-A (Cl⁻); Glycine (Cl⁻)mAChR (M1–M5); α/β-adrenergic; dopamine (D1–D5); opioid (μ, δ, κ); 5-HT (most subtypes)
Drug targetsBenzodiazepines (GABA-A); curare (nAChR); nerve agents (AChE)Atropine, β-blockers, antipsychotics, opioids, SSRIs
Aviation Application — Pharmacological agents and aviation fitness

The receptor pharmacology described in this section is directly relevant to aeromedical fitness evaluations. Virtually every class of centrally or autonomically active drug modulates specific neurotransmitter receptors and has performance implications for aviators. Antihistamines (H1 antagonists) cause sedation by blocking histaminergic arousal pathways — even ‘non-drowsy’ formulations may impair cognitive performance at high doses. Benzodiazepines enhance GABA-A inhibition, producing sedation and anterograde amnesia incompatible with flight duties. SSRIs modulate serotonergic transmission and while generally better tolerated, require individual evaluation. Stimulants (amphetamines, modafinil) enhance monoaminergic transmission and may be prescribed for shift-work disorders in military contexts — each requires careful assessment of on-drug and off-drug performance profiles. Medication assessments depend on understanding the receptor mechanisms, half-lives, and performance profiles of these agents.

NMDA receptor excitotoxicity during hypoxia: When cerebral blood flow is severely reduced (during G-LOC, near-drowning, or cardiac arrest), dying neurons release glutamate in massive quantities. This glutamate flood activates NMDA receptors on adjacent neurons, allowing massive Ca²⁺ influx that activates proteases, phospholipases, and endonucleases, triggering secondary cell death — excitotoxicity. This cascade occurs AFTER initial hypoxic injury and represents a significant fraction of the neuronal loss following brief ischemic events. The window for neuroprotective intervention extends into the minutes to hours after the primary event, which is why rapid restoration of cerebral perfusion (emergency descent, oxygen delivery, and BLS following G-LOC or hypoxic events) is critical.

High-Yield Summary
  • ACh: Excitatory at NMJ (nicotinic) and autonomic ganglia; variable at muscarinic. Degraded by AChE. Nerve agents block AChE.
  • Glutamate: Primary CNS excitatory transmitter. AMPA = fast EPSP. NMDA = Ca²⁺ influx + synaptic plasticity (coincidence detector). Excitotoxicity during ischemia.
  • GABA: Primary CNS inhibitory transmitter. GABA-A (ionotropic, Cl⁻) = fast IPSP. Benzodiazepines/alcohol/barbiturates potentiate GABA-A → sedation → aviation hazard.
  • Glycine: Spinal cord / brainstem inhibitory transmitter. Ionotropic Cl⁻ channel. Strychnine blocks it → tetanic spasms.
  • Dopamine: Reward, motor control, motivation. Metabotropic D1–D5. Loss → Parkinson’s. Excess → schizophrenia.
  • NE: Arousal, attention, sympathetic effector. α1/α2/β1/β2 adrenergic (all GPCRs).
  • Ionotropic: Fast (ms); direct ion channel; examples = nAChR, AMPA, NMDA, GABA-A, glycine.
  • Metabotropic (GPCR): Slow (sec–min); G-protein → second messengers; amplified; examples = mAChR, adrenergic, dopamine, opioid.
Objective 4.14

Describe the anatomical organization of the autonomic nervous system, distinguishing between sympathetic and parasympathetic divisions.

Objective 4.15

Identify the neurotransmitters and receptor types of the sympathetic and parasympathetic divisions and the functional responses they produce.

Objective 4.16

Describe the functional roles of the sympathetic and parasympathetic divisions in regulating cardiovascular, respiratory, and gastrointestinal functions, with specific attention to their roles in the aviation environment.

The autonomic nervous system (ANS) is the involuntary motor division of the nervous system that continuously regulates the internal environment — maintaining homeostasis of cardiovascular, respiratory, gastrointestinal, glandular, and reproductive functions. Unlike the somatic motor system (which requires conscious volition to act), the ANS operates continuously and largely below the level of conscious awareness. It is organized into two functionally antagonistic divisions — sympathetic and parasympathetic — that exert opposing effects on most target organs, allowing the organ’s output to be precisely tuned between two extremes. In the aviation environment, the sympathetic division is the first-line cardiovascular defender against G-loading, the mediator of the stress response, and the target of multiple pharmacological agents. The parasympathetic division, while quieter in tactical flight, is the dominant system at rest, the driver of bunt bradycardia, and the system that must re-establish dominance rapidly during flight’s briefer, calmer phases.

Anatomical Organization of the ANS (Objective 4.14)

The Two-Neuron Efferent Chain

All autonomic efferent pathways consist of two neurons in series19: a preganglionic neuron (with its cell body in the CNS and its axon projecting to a peripheral ganglion) and a postganglionic neuron (with its cell body in the peripheral ganglion and its axon projecting to the target organ). This two-neuron arrangement contrasts with the single-neuron motor pathway of the somatic nervous system (spinal motor neuron directly to skeletal muscle). The peripheral ganglia are the sites where central ANS commands are relayed to the periphery — and where pharmacological interventions (ganglionic blockers) can interrupt autonomic signaling.

Sympathetic Division: Thoracolumbar Outflow

Sympathetic preganglionic cell bodies are located in the lateral horn of the thoracic (T1–T12) and upper lumbar (L1–L2) spinal cord — the thoracolumbar outflow19. Short preganglionic fibers (type B, lightly myelinated) project to one of two types of ganglia:

  • Paravertebral (sympathetic chain) ganglia: Two chains of ganglia running bilaterally along the vertebral column from cervical to sacral levels. Most sympathetic fibers synapse here, producing relatively diffuse activation (one preganglionic fiber synapses on many postganglionic neurons — divergence ratio up to 1:100, enabling widespread ‘fight or flight’ responses).
  • Prevertebral (collateral) ganglia: Located near the aorta and its branches: celiac ganglion (GI), superior mesenteric ganglion (small intestine), inferior mesenteric ganglion (large intestine/rectum). Serve the abdominal organs.
  • Adrenal medulla: The exception — preganglionic sympathetic fibers project directly to chromaffin cells of the adrenal medulla without a postganglionic neuron. Chromaffin cells are modified postganglionic neurons that secrete epinephrine (80%) and norepinephrine (20%)19 directly into the bloodstream, allowing systemic hormonal reinforcement of the neural sympathetic response.

Long postganglionic sympathetic fibers (type C, unmyelinated) project from ganglia to target organs. Sympathetic innervation is widespread — essentially all organs receive sympathetic input (including the heart, blood vessels, lungs, GI tract, sweat glands, pupils, and the adrenal medulla).

Parasympathetic Division: Craniosacral Outflow

Parasympathetic preganglionic cell bodies are located in two regions: the brainstem (cranial outflow, associated with cranial nerves III, VII, IX, X) and the sacral spinal cord (S2–S4, sacral outflow)19. This craniosacral outflow innervates more restricted targets than the sympathetic division.

  • Cranial parasympathetic outflow (CN III, VII, IX, X): CN III (oculomotor) → ciliary ganglion → pupillary constriction + lens accommodation. CN VII (facial) → pterygopalatine and submandibular ganglia → lacrimal, salivary, nasal glands. CN IX (glossopharyngeal) → otic ganglion → parotid gland. CN X (vagus) → terminal ganglia in thoracic and abdominal viscera → heart, lungs, esophagus, stomach, small intestine, proximal colon, liver, pancreas, kidneys.
  • Sacral parasympathetic outflow (S2–S4): Pelvic splanchnic nerves → pelvic ganglia → distal colon, rectum, bladder, reproductive organs. ‘Erection is parasympathetic, ejaculation is sympathetic.’

Parasympathetic ganglia are located close to or within the wall of the target organ (terminal ganglia), making postganglionic fibers very short. Divergence is minimal (1 preganglionic : 1–3 postganglionic), enabling discrete, localized responses — in contrast to the diffuse sympathetic activation.

Table 4.7. Anatomical and Pharmacological Comparison: Sympathetic vs. Parasympathetic Divisions

FeatureSympathetic DivisionParasympathetic Division
Origin (Outflow)Thoracolumbar (T1–L2 lateral horn)Craniosacral (CN III, VII, IX, X + S2–S4)
Preganglionic fiber lengthShort (synapse in paravertebral or prevertebral ganglia)Long (travel to terminal ganglia in/near target organ)
Ganglion locationParavertebral chain or prevertebral (celiac, mesenteric)Within or near target organ (terminal ganglia)
Postganglionic fiber lengthLong (unmyelinated C fibers)Short (unmyelinated C fibers)
Divergence ratioHigh (1:100 or more) → diffuse, widespread responseLow (1:1–3) → discrete, localized response
Preganglionic transmitterAcetylcholine (nicotinic nAChR)Acetylcholine (nicotinic nAChR)
Postganglionic transmitterNorepinephrine (most organs); ACh (sweat glands, some vasodilators)Acetylcholine (muscarinic mAChR)
Special featureAdrenal medulla: direct preganglionic innervation → Epi + NE release into bloodstreamVagus nerve innervates 75% of all parasympathetic targets
Overall functionFight/flight/freeze: mobilize resources for acute stressRest/digest: conserve resources, promote anabolism

Neurotransmitters and Receptors (Objective 4.15)

The ANS uses acetylcholine and norepinephrine as its primary transmitters, but in a carefully segregated pattern:

Cholinergic Synapses (ACh Released)

  • All preganglionic neurons (both sympathetic and parasympathetic) → release ACh19 → bind nicotinic nAChR on postganglionic neurons.
  • All parasympathetic postganglionic neurons → release ACh18 → bind muscarinic mAChR on target organs.
  • Sympathetic postganglionic neurons to sweat glands → release ACh → bind muscarinic mAChR.
  • Somatic motor neurons to skeletal muscle → release ACh → bind nicotinic nAChR (muscle-type).

Adrenergic Synapses (NE Released)

  • Most sympathetic postganglionic neurons → release NE → bind α or β adrenergic receptors on target organs.

Table 4.8. Adrenergic Receptor Subtypes: G-Protein Coupling, Location, and Functional Responses

Adrenergic ReceptorTypeG-ProteinPrimary LocationsResponse to NE/Epi
α1Metabotropic (GPCR)Gq (↑ IP3/DAG → ↑ intracellular Ca²⁺)Vascular smooth muscle; iris dilatorVasoconstriction (most vessels); pupil dilation
α2Metabotropic (GPCR)Gi (↓ cAMP)Presynaptic autoreceptors; pancreatic β-cellsFeedback inhibition of NE release; ↓ insulin
β1Metabotropic (GPCR)Gs (↑ cAMP → PKA)SA node; AV node; ventricular myocardium↑ HR (chronotropy); ↑ conduction (dromotropy); ↑ contractility (inotropy)
β2Metabotropic (GPCR)Gs (↑ cAMP)Bronchiolar smooth muscle; skeletal muscle vasculature; uterusBronchodilation; vasodilation in skeletal muscle (Epi>NE)
β3Metabotropic (GPCR)Gs (↑ cAMP)Adipose tissueLipolysis (fatty acid mobilization)

Table 4.9. Muscarinic Receptor Subtypes: G-Protein Coupling, Location, and Functional Responses

Muscarinic ReceptorTypeG-ProteinPrimary LocationsResponse to ACh
M1Metabotropic (GPCR)Gq (↑ IP3/DAG)CNS (cortex, hippocampus); gastric parietal cellsCognitive enhancement; ↑ gastric acid secretion
M2Metabotropic (GPCR)Gi (↓ cAMP; activates IKACh)SA node; AV node; ventricular muscle; presynaptic↓ HR; ↓ conduction; slight ↓ contractility
M3Metabotropic (GPCR)Gq (↑ IP3/DAG)Smooth muscle (GI, bladder, airway); exocrine glands; vascular endotheliumBronchoconstriction; ↑ secretions; GI motility; ↑ salivation; vasodilation via NO from endothelium

Functional Roles in the Aviation Environment (Objective 4.16)

Cardiovascular System

The cardiovascular effects of the ANS are among the most operationally critical in aviation physiology:

  • Sympathetic cardiovascular effects: β1 receptors at SA node → ↑ HR (chronotropy); β1 at AV node → faster conduction (dromotropy, ↓ PR interval); β1 at ventricular myocardium → ↑ contractility (inotropy); α1 at arterioles (especially splanchnic and cutaneous) → vasoconstriction → ↑ SVR → ↑ MAP; NE + Epi cause venoconstriction → ↑ venous return → ↑ preload.
  • Parasympathetic cardiovascular effects: Vagal M2 receptors at SA node → ↓ HR (dominant at rest); M2 at AV node → slower conduction (↑ PR interval); minimal direct effect on ventricles (sparse vagal innervation). Removal of vagal tone (at exercise onset or G-loading) immediately raises HR.
  • G-loading cardiovascular response: Carotid sinus baroreceptors detect falling cephalic blood pressure → baroreceptor reflex → sympathetic ↑ (HR, contractility, vasoconstriction) + parasympathetic ↓ (vagal withdrawal). This reflex is the primary cardiovascular defense against G-LOC1011. The AGSM enhances the reflex by preventing peripheral venous pooling.

Respiratory System

  • Sympathetic bronchial effects: β2 receptors on bronchiolar smooth muscle → bronchodilation. Epinephrine (from adrenal medulla) is the primary sympathetic mediator of acute bronchodilation. This is the pharmacological basis for epinephrine in anaphylaxis and albuterol (a β2 agonist) in asthma. In high-G flight and during the AGSM, sympathoadrenal activation aids in maintaining airway patency against the increased respiratory muscle workload.
  • Parasympathetic bronchial effects: M3 receptors on bronchiolar smooth muscle → bronchoconstriction + ↑ mucus secretion. Cholinergic bronchoconstriction is the dominant mechanism of airway narrowing in asthma. Vagal tone is the normal resting baseline of airway smooth muscle; anticholinergic drugs (ipratropium) block M3 receptors and are used to treat bronchospasm.

Gastrointestinal System

  • Sympathetic GI effects: α1 receptors on GI vasculature → vasoconstriction (reduces gut blood flow during stress to redirect to muscles/heart/brain). α1 and α2 receptors on enteric neurons and smooth muscle → ↓ motility, ↓ secretion, ↑ sphincter tone. The classic ‘flight’ response essentially suspends GI activity.
  • Parasympathetic GI effects: M3 receptors on GI smooth muscle → ↑ motility (‘rest and digest’). M3 on gastric cells → ↑ secretion. CN X innervates the entire GI tract from esophagus to proximal colon; sacral outflow serves distal colon and rectum.

Other Autonomic Effector Organs: Quick Reference

Table 4.10. Autonomic Effects on Major Organ Systems

Organ / FunctionSympathetic Effect (NE/Epi)ReceptorParasympathetic Effect (ACh)Receptor
Heart rate↑ (Chronotropy)β1↓ (Chronotropy)M2
Heart contractility↑ (Inotropy)β1Slight ↓ (atria)M2
Blood vessels (skin, viscera)Constriction (↑ SVR)α1Dilation (via endothelial NO)M3
Blood vessels (skeletal muscle)Dilation (Epi only via β2)β2No innervation
BronchiolesDilationβ2Constriction + ↑ secretionsM3
PupilDilation (mydriasis)α1Constriction (miosis)M3
Lens ciliary muscleRelaxation (distant focus)β2Contraction (near focus / accommodation)M3
GI motility↓ (Inhibition)β1/β2↑ (Stimulation)M3
GI sphinctersContraction (↑ tone)α1RelaxationM3
Salivary glandsScant, viscous secretionα1Profuse, watery secretionM3
Sweat glandsSecretion (↑ sweating)M (cholinergic sympathetic)None
Adrenal medullaEpi + NE secretionnAChR (direct preganglionic)None
Bladder wall (detrusor)Relaxation (urinary retention)β2Contraction (urination)M3
Bladder sphincterContraction (retention)α1Relaxation (voiding)M3
Glycogenolysis / lipolysis↑ (energy mobilization)β3; β1None
Aviation Application — Anticholinergic drugs and aeromedical grounding

Anticholinergic medications — drugs that block muscarinic receptors (M1–M5) — are among the most common classes relevant to aviation fitness evaluations. Antihistamines with anticholinergic properties (diphenhydramine, promethazine), antidepressants with anticholinergic side effects (tricyclics), antispasmodics, and scopolamine (prescribed for motion sickness) all block muscarinic receptors. The clinical consequences — dry mouth, urinary retention, constipation, blurred vision (M3 effects), and importantly tachycardia (M2 blockade removing parasympathetic cardiac braking) and CNS impairment (M1 blockade) — make these drugs generally incompatible with flying duties during the pharmacological effect window. Particularly relevant is the CNS anticholinergic syndrome: confusion, delirium, and impaired cognitive performance from central M1/M4 blockade. Medication-compatibility decisions depend on which muscarinic receptor subtype mediates each effect.

The sympathoadrenal response as the G-tolerance determinant: The sympathetic nervous system’s response to falling blood pressure during +Gz loading is a cascade of precisely timed events: baroreceptor firing falls → vasomotor center activated → sympathetic outflow increases within 1–2 seconds → HR rises (β1), contractility increases (β1), arterioles constrict (α1), veins constrict (mobilizing venous reservoir), adrenal medulla releases Epi + NE (within 30–60 seconds). Each element of this response is a node where pharmacological agents can enhance or impair G-tolerance. Beta-blockers blunt the β1 response (HR and contractility cannot increase appropriately). Alpha-blockers prevent the vasoconstriction essential for maintaining MAP. Conversely, dehydration reduces the volume available for the venoconstriction reserve. Understanding the ANS pharmacology of G-tolerance is essential for aeromedical practitioners evaluating aircrew on any cardiovascular or autonomic medication.

Motion sickness and the ANS: Motion sickness — a nearly universal human response to certain patterns of visual-vestibular conflict — is mediated partly through autonomic pathways. The nausea, pallor, cold sweats, and vomiting of motion sickness reflect a combination of parasympathetic (vagal) activity (nausea, salivation, bradycardia) and sympathetic activity (pallor from cutaneous vasoconstriction, sweating). The antiemetic drug promethazine (used in military aviation for motion sickness control) blocks both H1 histamine receptors and muscarinic receptors, but its central anticholinergic and sedating effects make it incompatible with flying. The search for a non-sedating, non-cognitive-impairing antiemetic for aviators remains an active area in aerospace pharmacology.

High-Yield Summary
  • ANS two-neuron chain: Preganglionic (CNS → ganglion; ACh → nAChR) + Postganglionic (ganglion → target; NE or ACh).
  • Sympathetic: Thoracolumbar (T1–L2). Short preganglionic, long postganglionic. High divergence (1:100)19. NE → α/β adrenergic receptors at target organs.
  • Parasympathetic: Craniosacral (CN III, VII, IX, X; S2–S4). Long preganglionic, short postganglionic. Low divergence (1:1–3). ACh → muscarinic receptors at target organs.
  • Both preganglionic neurons: ACh → nicotinic nAChR. Exception: adrenal medulla = direct preganglionic innervation → Epi + NE into bloodstream.
  • Adrenergic receptors: α1 (Gq; vasoconstriction); α2 (Gi; presynaptic feedback); β1 (Gs; ↑ HR, inotropy, dromotropy); β2 (Gs; bronchodilation, skeletal muscle vasodilation).
  • Muscarinic receptors: M2 (Gi; ↓ HR in SA/AV node); M3 (Gq; bronchoconstriction, GI motility, secretions, pupil constriction).
  • Sympathetic activation under +Gz: β1 (↑ HR + inotropy) + α1 (vasoconstriction) + venoconstriction + adrenal Epi release. Primary G-tolerance mechanism.
  • Beta-blockers blunt sympathetic G-tolerance response → generally disqualifying for high-G aviation.
  • Anticholinergic drugs block M2 (↑ HR) + M3 (mydriasis, GI inhibition) + CNS M1 (cognitive impairment) → generally grounding during effect window.

References

  1. 1. Hall, J. E., & Hall, M. E. (2021). Guyton and Hall Textbook of Medical Physiology (14th ed.). Elsevier.
  2. 2. Kandel, E. R., Schwartz, J. H., Jessell, T. M., Siegelbaum, S. A., & Hudspeth, A. J. (2013). Principles of Neural Science (5th ed.). McGraw-Hill.
  3. 3. Bear, M. F., Connors, B. W., & Paradiso, M. A. (2020). Neuroscience: Exploring the Brain (4th ed.). Wolters Kluwer.
  4. 4. Hille, B. (2001). Ion Channels of Excitable Membranes (3rd ed.). Sinauer Associates.
  5. 5. Hodgkin, A. L., & Huxley, A. F. (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. Journal of Physiology, 117(4), 500–544. doi.org/10.1113/jphysiol.1952.sp004764
  6. 6. Erlanger, J., & Gasser, H. S. (1937). Electrical Signs of Nervous Activity. University of Pennsylvania Press.
  7. 7. Südhof, T. C. (2013). Neurotransmitter release: The last millisecond in the life of a synaptic vesicle. Neuron, 80(3), 675–690. doi.org/10.1016/j.neuron.2013.10.022
  8. 8. Loewi, O. (1921). Über humorale Übertragbarkeit der Herznervenwirkung. Pflügers Archiv für die gesamte Physiologie, 189(1), 239–242. doi.org/10.1007/BF01738910
  9. 9. Langley, J. N. (1921). The Autonomic Nervous System (Part 1). Heffer.
  10. 10. DeHart, R. L., & Davis, J. R. (Eds.). (2002). Fundamentals of Aerospace Medicine (3rd ed.). Lippincott Williams & Wilkins.
  11. 11. Ernsting, J., Nicholson, A. N., & Rainford, D. J. (Eds.). (1999). Aviation Medicine (3rd ed.). Butterworth Heinemann.
  12. 12. Netter, F. H. (2019). Atlas of Human Anatomy (7th ed.). Elsevier.
  13. 13. Skou, J. C. (1957). The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochimica et Biophysica Acta, 23, 394–401. doi.org/10.1016/0006-3002(57)90343-8
  14. 14. Bliss, T. V. P., & Lømo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. Journal of Physiology, 232(2), 331–356. doi.org/10.1113/jphysiol.1973.sp010273

More aerospace physiology topics